Press "esc" to clear
Go to Advanced Search

Showing results

110 of 619
Daphne_Lichtensztajn.jpg
  • Embargo expired:
    15-Nov-2018 9:00 AM EST

Article ID: 704043

Latino Men are Much Less Likely to Receive Optimal Treatment for High Risk Prostate Cancer than White Men, According to New Research in JNCCN

National Comprehensive Cancer Network® (NCCN®)

New research published in JNCCN-Journal of the National Comprehensive Cancer Network found Latino men were 21% less likely to receive definitive treatment compared to non-Latino white men, with significant differences for younger patients, the uninsured, and those treated at NCI-designated centers.

Released:
14-Nov-2018 4:45 PM EST

Article ID: 703938

Prostates and Personalities: Tulane Study Finds Neurotic or Introverted Men More Likely to Be Distressed After Cancer Diagnosis

Tulane University

Men who are neurotic or introverted are more likely to be distressed after their prostate cancer diagnosis, according to a new study by researchers at Tulane University.

Released:
13-Nov-2018 4:05 PM EST

Article ID: 703680

First-ever prostate cancer treatment uses gold nanoparticles to destroy tumorous cells

University of Texas Health Science Center at Houston

A small clinical trial using gold nanoparticles that act as tumor-seeking missiles on a mission to remove prostate cancer has begun at The University of Texas Health Science Center at Houston (UTHealth). It is the first trial of its kind in the world.

Released:
8-Nov-2018 4:05 PM EST
CELL-REPORTS-D-18-00393_R2.jpg

Article ID: 703048

Single Protein Controls Thousands of Genes Essential for Sperm Development

Case Western Reserve University

A single protein regulates a battery of key genes inside developing sperm, according to a new study out of Case Western Reserve University School of Medicine. Scientists discovered the protein—called Dazl—controls a network of genes essential for developing sperm to replicate and survive. The findings, published in Cell Reports, could lay the groundwork for future research into therapies for infertile men.

Released:
30-Oct-2018 11:05 AM EDT
0925_capscore.jpg

Article ID: 702734

New Test Measures Men’s Fertility

Cornell University

At a time when more than half of male infertility cannot be explained by current methods, a new test developed by Androvia LifeSciences is able to measure male fertility. The proprietary Cap-Score Male Fertility Assay is based on research patented by the Travis lab at the Baker Institute for Animal Health and Cornell University’s College of Veterinary Medicine and was recently the subject of a study that appeared Sept. 24 in the journal Molecular Reproduction and Development.

Released:
24-Oct-2018 12:45 PM EDT
31214948722_fa91b4767c_z.jpg

Article ID: 702351

Fight CRC Partners with No-Shave November for Fourth Straight Year

Fight Colorectal Cancer

Fight Colorectal Cancer (Fight CRC) has once again been selected by No-Shave November as one of the three recipients for all funds raised during the 2018 campaign.

Released:
23-Oct-2018 12:05 PM EDT
  • Embargo expired:
    22-Oct-2018 12:00 PM EDT

Article ID: 702534

Combined therapy including pelvic lymph node radiation provides significant benefit for prostate cancer patients

American Society for Radiation Oncology (ASTRO)

The first report of a large international clinical trial shows that, for men who show signs of prostate cancer after surgical removal of their prostates, extending radiation therapy to the pelvic lymph nodes combined with adding short-term hormone therapy to standard treatment can extend the amount of time before their cancer spreads. Findings will be presented in a news briefing today at noon ET from the American Society for Radiation Oncology (ASTRO) Annual Meeting.

Released:
22-Oct-2018 12:00 AM EDT
  • Embargo expired:
    22-Oct-2018 12:00 PM EDT

Article ID: 702535

Radiation Therapy Outcomes Better for African-American Prostate Cancer Patients Than Caucasian Patients

American Society for Radiation Oncology (ASTRO)

While popular beliefs and population data suggest that African-American men are at higher risk of dying from prostate cancer than Caucasian men, a new analysis of genetic data from a large prospective registry and clinical data from several randomized trials indicates that African-American patients may have comparatively higher cure rates when treated with radiation therapy. Findings will be presented in a news briefing today at noon ET from the American Society for Radiation Oncology (ASTRO) Annual Meeting.

Released:
21-Oct-2018 11:05 PM EDT
  • Embargo expired:
    22-Oct-2018 12:00 PM EDT

Article ID: 702536

Men with low- and intermediate-risk prostate cancer can safely benefit from fewer, higher-dose radiation treatments

American Society for Radiation Oncology (ASTRO)

Stereotactic body radiation therapy (SBRT) is a safe and effective treatment for men with low- and intermediate-risk prostate cancer, according to a long-term, multi-institutional study. The study clears the way for patients who may wish to shorten their course of treatment without fear of increasing their risk for severe, adverse side effects. Findings will be presented in a news briefing today at noon ET from the American Society for Radiation Oncology (ASTRO) Annual Meeting.

Released:
21-Oct-2018 11:05 PM EDT

Article ID: 702555

Study Indicates That Fathers Who Exercise Before Conception Produce Children Who Are Healthier Throughout Their Lives

Joslin Diabetes Center

Recent studies have linked development of type 2 diabetes and impaired metabolic health individuals to their parents’ poor diet, and there is increasing evidence that fathers play an important role in obesity and metabolic programming of their offspring.In a new study published today in the journal Diabetes, researchers at Joslin Diabetes Center have shown that paternal exercise has a significant impact on the metabolic health of their offspring well into adulthood.

Released:
22-Oct-2018 10:05 AM EDT

Showing results

110 of 619

Chat now!